Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NC-ND 4.0Turkish Journal of Ophthalmology

Long-Term Ocular and Neurodevelopmental Outcomes of Retinopathy of Prematurity: A Bibliometric and Thematic Evolution Analysis

  1. 1Ağrı İbrahim Çeçen University Faculty of Medicine, Department of Ophthalmology, Ağrı, Türkiye
  2. 2Ağrı İbrahim Çeçen University Faculty of Medicine, Department of Histology and Embryology, Ağrı, Türkiye

Abstract

Objectives: To map the global research landscape on the long-term outcomes of retinopathy of prematurity (ROP) and quantify the representation of four clinically relevant outcome domains: visual and refractive outcomes, structural retinal and macular sequelae, late post-treatment complications, and neurodevelopmental and quality-of-life outcomes.

Materials and Methods: Two Web of Science Core Collection datasets were created on July 21, 2026 and limited to English-language original articles: Dataset A (general long-term ROP outcomes) and Dataset B (long-term outcomes after ROP treatment). Bibliometric analyses were performed in R using the bibliometrix package. A predefined 108-term outcome lexicon was applied to merged Author Keywords and Keywords Plus. Domain distributions were compared using the chi-square test, and representation ratios were calculated with 95% confidence intervals (CI).

Results: Dataset A included 6,946 articles from 1,035 sources, whereas Dataset B included 1,296 articles from 238 sources. The United States was the leading contributor in both datasets. Türkiye ranked third and fourth in publication output but showed the lowest international collaboration rate (0.9%) among leading countries. Visual and refractive outcomes were the most frequently represented domain (1.95% and 4.07% of keyword occurrences), whereas neurodevelopmental and quality-of-life outcomes were the least represented and the only domain underrepresented in the treatment literature (0.60% vs. 0.35%; representation ratio 0.59, 95% CI 0.43-0.83; p=0.003).

Conclusion: Research on long-term ROP outcomes is expanding rapidly, but the transition from acute treatment to survivorship remains incomplete. Greater emphasis on neurodevelopmental and quality-of-life outcomes and stronger international collaboration are needed.

Related

  1. Neurodevelopmental Disorders in Infants Treated with Anti-VEGF Agents versus Laser Photocoagulation or Cryotherapy for Retinopathy of Prematurity
    Inès Ben Ghezala, Caroline Bonnet, Caroline Conese +4
    Ophthalmology sciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Explainability-informed patient-disjoint evaluation of deep learning for plus disease in retinopathy of prematurity with an ophthalmologist reader study
    Rouhollah Kian Ara, Jan Kubíček, Sumit Kaushik +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Predicting Retinopathy of Prematurity in Thailand: A Practical Model for Risk-Based Screening
    Suppachai Lawanaskol, Jayanton Patumanond, Phichayut Phinyo +6
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Reduced serum Dickkopf-1 levels as a potential supportive biomarker for the development and severity of retinopathy of prematurity: a prospective observational clinical study
    Nuriye Emiroğlu, Hasan Çetin, Hüseyin Altunhan +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Cost-Effectiveness of Telemedicine-Based Screening Programs for Retinopathy of Prematurity in Low- and Middle-Income Countries
    Sarthak V. Shah, Arthur Brant, Michael R. James +10
    Ophthalmology sciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{karatas2026longterm,
  title = {{Long-Term Ocular and Neurodevelopmental Outcomes of Retinopathy of Prematurity: A Bibliometric and Thematic Evolution Analysis}},
  author = {Ezgi Karataş and Seçil Nazife Parlak and Merve Nur Güney and Yavuz Oruç},
  journal = {Turkish Journal of Ophthalmology},
  year = {2026},
  month = oct,
  doi = {10.4274/tjo.galenos.2026.03947},
  url = {https://doi.org/10.4274/tjo.galenos.2026.03947},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Long-Term Ocular and Neurodevelopmental Outcomes of Retinopathy of Prematurity: A Bibliometric and Thematic Evolution Analysis
AU  - Ezgi Karataş
AU  - Seçil Nazife Parlak
AU  - Merve Nur Güney
AU  - Yavuz Oruç
PY  - 2026
DA  - 2026/10/01
JO  - Turkish Journal of Ophthalmology
DO  - 10.4274/tjo.galenos.2026.03947
UR  - https://doi.org/10.4274/tjo.galenos.2026.03947
AB  - Objectives: To map the global research landscape on the long-term outcomes of retinopathy of prematurity (ROP) and quantify the representation of four clinically relevant outcome domains: visual and refractive outcomes, structural retinal and macular sequelae, late post-treatment complications, and neurodevelopmental and quality-of-life outcomes.  Materials and Methods: Two Web of Science Core Collection datasets were created on July 21, 2026 and limited to English-language original articles: Dataset A (general long-term ROP outcomes) and Dataset B (long-term outcomes after ROP treatment). Bibliometric analyses were performed in R using the bibliometrix package. A predefined 108-term outcome lexicon was applied to merged Author Keywords and Keywords Plus. Domain distributions were compared using the chi-square test, and representation ratios were calculated with 95% confidence intervals (CI).  Results: Dataset A included 6,946 articles from 1,035 sources, whereas Dataset B included 1,296 articles from 238 sources. The United States was the leading contributor in both datasets. Türkiye ranked third and fourth in publication output but showed the lowest international collaboration rate (0.9%) among leading countries. Visual and refractive outcomes were the most frequently represented domain (1.95% and 4.07% of keyword occurrences), whereas neurodevelopmental and quality-of-life outcomes were the least represented and the only domain underrepresented in the treatment literature (0.60% vs. 0.35%; representation ratio 0.59, 95% CI 0.43-0.83; p=0.003).  Conclusion: Research on long-term ROP outcomes is expanding rapidly, but the transition from acute treatment to survivorship remains incomplete. Greater emphasis on neurodevelopmental and quality-of-life outcomes and stronger international collaboration are needed.
SN  - 2149-8695
SN  - 2149-8709
ER  -